By April Joyner
NEW YORK (Reuters) - Wall Street's major indexes dipped on Friday in low trading volume before the holiday weekend as several blue-chip stocks slipped, including Nike.
Nike Inc
UnitedHealth Group Inc
Investors are winding down ahead of Christmas on Monday, when the market will be closed.
"It's been a strong week," said Mark Luschini, chief investment strategist at Janney Montgomery Scott in Philadelphia. "Whether the market is up a little bit or down a little bit is not indicative of larger trends ... It's easy to push things around when not many people are trading."
Indeed, major Wall Street indexes were on track to end the week higher, buoyed by a historic overhaul of the U.S. tax code.
More From This Section
President Donald Trump signed Republicans' massive $1.5-trillion tax overhaul into law on Friday and also approved a short-term spending bill that averts a possible government shutdown.
The Dow Jones Industrial Average <.DJI> fell 28.23 points, or 0.11 percent, to 24,754.06, the S&P 500 <.SPX> lost 1.23 points, or 0.05 percent, to 2,683.34 and the Nasdaq Composite <.IXIC> dropped 5.40 points, or 0.08 percent, to 6,959.96.
For the week, the Dow rose 0.42 percent, the S&P gained 0.29 percent and the Nasdaq added 0.34 percent.
Wildly volatile bitcoin > plunged below $12,000, losing around a third of its market value in five days, before rebounding to above $14,000. Companies that have been riding the bitcoin wave were hit hard by the cryptocurrency's slump.
Long Blockchain Corp
Data on Friday showed U.S. consumer spending went up in November and shipments of key capital goods orders increased for the 10th straight month, confirming strong economic momentum.
The benchmark S&P has climbed about 20 percent this year and is on track for its best performance since 2013 on solid corporate earnings, strong economic fundamentals, upcoming cuts to corporate tax rates and hopes of looser regulations.
Real estate <.SPLRCR> led the S&P 500 in gains, with a 0.7 percent rise. Health <.SPXHC> was the biggest decliner, falling 0.3 percent.
Celgene Corp
Advancing issues outnumbered declining ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.30-to-1 ratio favored decliners.
Volume on U.S. exchanges was 4.81 billion shares, compared to the 6.98 billion average for the full session over the last 20 trading days.
(Additional reporting by Sruthi Shankar in Bengaluru; Editing by Lisa Shumaker and Nick Zieminski)
Disclaimer: No Business Standard Journalist was involved in creation of this content